Mucosal ablation of Barrett esophagus

Nature Reviews Gastroenterology and Hepatology

Volumn 6, Issue 7, 2009, Pages 393-401

  Waxman, Irving ^a   Konda, Vani J A ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; OMEPRAZOLE; PHOTOFRIN; PROTON PUMP INHIBITOR;

ARGON PLASMA COAGULATION; BARRETT ESOPHAGUS; CANCER RISK; CLINICAL TRIAL; CRYOTHERAPY; DISEASE SURVEILLANCE; DRUG MEGADOSE; DYSPLASIA; ELECTROCOAGULATION; ENDOSCOPIC MUCOSAL RESECTION; ENDOSCOPIC THERAPY; ESOPHAGUS BIOPSY; ESOPHAGUS CANCER; ESOPHAGUS DILATATION; ESOPHAGUS RESECTION; ESOPHAGUS STRICTURE; GASTROINTESTINAL ENDOSCOPY; HUMAN; LOW LEVEL LASER THERAPY; NEODYMIUM LASER; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; REMISSION; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; TREATMENT INDICATION;

BARRETT ESOPHAGUS; ENDOSCOPY, GASTROINTESTINAL; ESOPHAGEAL NEOPLASMS; HUMANS; MUCOUS MEMBRANE;

EID: 67650859991     PISSN: 17595045     EISSN: 17595053     Source Type: Journal    
DOI: 10.1038/nrgastro.2009.90     Document Type: Review

References (74)

1. Shaheen, N. J., Crosby, M. A., Bozymski, E. M. & Sandler, R. S. Is there publication bias in the reporting of cancer risk in Barrett's esophagus? Gastroenterology 119, 333-338 (2000).
2. Rastogi, A. et al. Incidence of esophageal adenocarcinoma in patients with Barrett's esophagus and high-grade dysplasia: A metaanalysis. Gastrointest. Endosc. 67, 394-398 (2008).
3. Konda, V. J. A. et al. is the risk of concomitant invasive esophageal cancer in high grade dysplasia in Barrett's esophagus overestimated? Clin. Gastroenterol. Hepatol. 6, 159-164 (2008).
4. Ferguson, M. K. & Naunheim, K. S. Resection for Barrett's mucosa with high-grade dysplasia: Implications for prophylactic photodynamic therapy. J. Thorac. Cardiovasc. Surg. 114, 824-829 (1997).
5. Pellegrini, C. A. & Pohl, D. High-grade dysplasia in Barrett's esophagus: Surveillance or operation? J. Gastrointest. Surg. 4 131-134 (2000).
6. Feith, M., Stein, H. J. & siewert, J. R. Pattern of lymphatic spread of Barrett's cancer. World J. Surg. 27, 1052-1057 (2003).
7. Rice, T. W. et al. Esophageal carcinoma: Depth of tumor invasion is predictive of regional node status. Ann. Thorac. Surg. 65 787-792 (1998).
8. Swisher, S. G. et al. Effect of operative volume on morbidity, mortality, and hospital use after esophagectomy for cancer. J. Thorac. Cardiovasc. Surg. 119, 1126-1132 (2000).
9. Tadiparthi, R., Bansal, A. & Sharma, P. What's new in columnar lined esophagus (Barrett's metaplasia)? Curr. Opin. Gastroenterol. 24 516-520 (2008).
10. Wani, S. et al. Esophageal adenocarcinoma in Barrett's esophagus after endoscopic ablative therapy: A meta-analysis and systematic review. Am. J. Gastroenterol. 104, 502-513 (2009).
11. Kerkhof, M. et al. Grading of dysplasia in Barrett's oesophagus: substantial interobserver variation between general and gastrointestinal pathologists. Histopathology 50, 920-927 (2007).
12. Palazzo, F., Fisichella, P. M. & Patti, M. G. Management of high-grade dysplasia. Curr. Gastroenterol. Rep. 10, 240-245 (2008).
13. Tharavej, C. et al. Predictive factors of coexisting cancer in Barrett's high-grade dysplasia. Surg. Endosc. 20, 439-443 (2006).
14. Buttar, N. S. et al. Extent of high-grade dysplasia in Barrett's esophagus correlates with risk of adenocarcinoma. Gastroenterology 120, 1630-1639 (2001).
15. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma - 2nd English edition. Gastric Cancer 1, 10-24 (1998).
16. Endoscopic Classification Review Group. Update on the Paris classification of superficial neoplastic lesions in the digestive tract. Endoscopy 37, 570-578 (2005).
17. Peters, F. P. et al. Histologic evaluation of resection specimens obtained at 293 endoscopic resections in Barrett's esophagus. Gastrointest. Endosc. 67, 604-609 (2008).
18. Sharma, P. et al. Non-biopsy detection of intestinal metaplasia and dysplasia in Barrett's esophagus: A prospective multicenter study. Endoscopy 38, 1206-1212 (2006).
19. Sharma, P. et al. The utility of a novel narrow band imaging endoscopy system in patients with Barrett's esophagus. Gastrointest. Endosc. 64, 167-175 (2006).
20. Hage, M. et al. Molecular evaluation of ablative therapy of Barrett's oesophagus. J. Pathol. 205, 57-64 (2005).
21. Pech, O. et al. Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett's oesophagus. Gut 57, 1200-1206 (2008).
22. Overholt, B. F. et al. Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus: international, partially blinded, randomized phase III trial. Gastrointest. Endosc. 62, 488-498 (2005).
23. Wang, K. K. & Sampliner, R. E. Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus; Practice Parameters Committee of the American College of Gastroenterology. Am. J. Gastroenterol. 103, 788-797 (2008).
24. Lewis, J. T., Wang, K. K. & Abraham, S. C. Muscularis mucosae duplication and the musculo-fibrous anomaly in endoscopic mucosal resections for Barrett esophagus: Implications for staging of adenocarcinoma. Am. J. Surg. Pathol. 32, 566-571 (2008).
25. Eguchi, T. et al. Histopathological criteria for additional treatment after endoscopic mucosal resection for esophageal cancer: analysis of 464 surgically resected cases. Mod. Pathol. 19, 475-480 (2006).
26. Manner, H. et al. early Barrett's carcinoma with "low-risk" submucosal invasion: Long-term results of endoscopic resection with a curative intent. Am. J. Gastroenterol. 103, 2589-2597 (2008).
27. Konda, V. J. et al. Low rate of invasive cancer in patients undergoing mucosectomy for Barrett's esophagus (Be) and high grade dysplasia (HGD) or intramucosal carcinoma (iMC) [Abstract]. Gastrointest. Endosc. 67, AB76 (2008).
28. ASGE technology committee et al. endoscopic mucosal resection and endoscopic submucosal dissection. Gastrointest. Endosc. 68, 11-18 (2008).
29. Abrams, J. A. et al. Depth of resection using two different endoscopic mucosal resection techniques. Endoscopy 40, 395-399 (2008).
30. May, A. et al. A prospective randomized trial of two different endoscopic resection techniques for early stage cancer of the esophagus. Gastrointest. Endosc. 58, 167-175 (2003).
31. Soehendra, N. et al. Use of modified multiband ligator facilitates circumferential EMR in Barrett's esophagus. Gastrointest. Endosc. 63, 847-852 (2006).
32. Peters, F. P. et al. Multiband mucosectomy for endoscopic resection of Barrett's esophagus: Feasibility study with matched historical controls. Eur. J. Gastroenterol. Hepatol. 19, 311-315 (2007).
33. Ell, C. et al. Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett's esophagus. Gastroenterology 118, 670-677 (2000).
34. May, A. et al. Local endoscopic therapy for intraepithelial high-grade neoplasia and early adenocarcinoma in Barrett's oesophagus: acute-phase and intermediate results of a new treatment approach. Eur. J. Gastroenterol. Hepatol. 14, 1085-1091 (2002).
35. May, A. et al. Intraepithelial high-grade neoplasia and early adenocarcinoma in short-segment Barrett's esophagus (SSBE): Curative treatment using local endoscopic treatment techniques. Endoscopy 34, 604-610 (2002).
36. Conio, M. et al. endoscopic mucosal resection for high-grade dysplasia and intramucosal carcinoma in Barrett's esophagus: An Italian experience. World J. Gastroenterol. 11, 6650-6655 (2005).
37. Ell, C. et al. Curative endoscopic resection of early esophageal adenocarcinoma (Barrett's cancer). Gastrointest. Endosc. 65, 3-10 (2007).
38. Larghi, A. et al. Long-term follow-up of complete Barrett's eradication endoscopic mucosal resection (CBe-eMr) for the treatment of high grade dysplasia and intramucosal carcinoma. Endoscopy 39 1086-1091 (2007).
39. Peters, F. P. et al. Stepwise radical endoscopic resection is effective for complete removal of Barrett's esophagus with early neoplasia: A prospective study. Am. J. Gastroenterol. 101, 1449-1457 (2006).
40. Seewald, S., Ang, T. L., Gotoda, T. & soehendra, N. Total endoscopic resection of Barrett esophagus. Endoscopy 40, 1016-1020 (2008).
41. Yoshinaga, S. et al. Clinical impact of endoscopic submucosal dissection for superficial adenocarcinoma located at the esophagogastric junction. Gastrointest. Endosc. 67, 202-209 (2008).
42. Overholt, B. F., Panjehpour, M. & Halberg, D. L. Photodynamic therapy for Barrett's esophagus with dysplasia and/or early stage carcinoma: long-term results. Gastrointest. Endosc. 58, 183-188 (2003).
43. Prasad, G. A. et al. Long-term survival following endoscopic and surgical treatment of highgrade dysplasia in Barrett's esophagus. Gastroenterology 132, 1226-1233 (2007).
44. Prasad, G. A. et al. Predictors of stricture formation after photodynamic therapy for highgrade dysplasia in Barrett's esophagus. Gastrointest. Endosc. 65, 60-66 (2007).
45. van Laethem, J. L., Peny, M. O., Salmon, I., Cremer, M. & Devière, J. intramucosal adenocarcinoma arising under squamous re-epithelialisation of Barrett's oesophagus. Gut 46, 574-577 (2000).
46. Ban, S. et al. Histopathologic aspects of photodynamic therapy for dysplasia and early adenocarcinoma arising in Barrett's esophagus. Am. J. Surg. Pathol. 28, 1466-1473 (2004).
47. Panjehpour, M., Coppola, D., Overholt, B. F., Vo-Dinh, T. & Overholt, s. Photodynamic therapy of Barrett's esophagus: Ablation of Barrett's mucosa and reduction in p53 protein expression after treatment. Anticancer Res. 28, 485-489 (2008).
48. Prasad, G. A. et al. Utility of biomarkers in prediction of response to ablative therapy in Barrett's esophagus. Gastroenterology 135, 370-379 (2008).
49. Wang, K. K. et al. Photodynamic therapy for Barrett's esophagus: does light still have a role? Endoscopy 40, 1021-1025 (2008).
50. Ganz, R. A. et al. Complete ablation of esophageal epithelium with a balloon-based bipolar electrode: A phased evaluation in the porcine and in the human esophagus. Gastrointest. Endosc. 60, 1002-1010 (2004).
51. Sharma, V. K. et al. Balloon-based, circumferential, endoscopic radiofrequency ablation of Barrett's esophagus: 1-year follow-up of 100 patients. Gastrointest. Endosc. 65, 185-195 (2007).
52. Fleischer, D. E. et al. endoscopic ablation of Barrett's esophagus: A multicenter study with 2.5-year follow-up. Gastrointest. Endosc. 68, 867-876 (2008).
53. Ganz, R. A. et al. Circumferential ablation of Barrett's esophagus that contains high-grade dysplasia: A U. S. multicenter registry. Gastrointest. Endosc. 68, 35-40 (2008).
54. Shaheen, N. et al. A randomized, multicenter, sham-controlled trial of radiofrequency ablation (RFA) for subjects with Barrett's esophagus (BE) containing dysplasia: Interim results of the AIM dysplasia trial [Abstract]. Gastroenterology 134, A37 (2008).
55. Gondrie, J. J. et al. effective treatment of early Barrett's neoplasia with stepwise circumferential and focal ablation using the HALO system. Endoscopy 40, 370-379 (2008).
56. Gondrie, J. J. et al. stepwise circumferential and focal ablation of Barrett's esophagus with high-grade dysplasia: Results of the first prospective series of 11 patients. Endoscopy 40, 359-369 (2008).
57. Gondrie, J. J. et al. Balloon-based circumferential ablation followed by focal ablation of Barrett's esophagus containing high-grade dysplasia effectively removes all genetic alterations [Abstract]. Gastroenterology 132, A64 (2007).
58. Johnston, M. H. et al. Cryoablation of Barrett's esophagus: A pilot study. Gastrointest. Endosc. 62, 842-848 (2005).
59. Greenwald, B. D. et al. endoscopic cryotherapy ablation is safe and well-tolerated in Barrett's esophagus, esophageal dysplasia, and esophageal cancer [Abstract]. Gastrointest. Endosc. 67, AB76 (2008).
60. 2-cryotherapy for high risk Barrett's esophagus (BE) patients with high grade dysplasia and early adenocarcinoma: A pilot trial of feasibility and safety [Abstract]. Gastrointest. Endosc. 67, AB179-AB180 (2008).
61. Dumot, J. A. & Greenwald, B. D. Argon plasma coagulation, bipolar cautery, and cryotherapy: ABC's of ablative techniques. Endoscopy 40, 1026-1032 (2008).
62. van Laethem, J. L., Cremer, M., Peny, M. O., Delhaye, M. & Devière, J. eradication of Barrett's mucosa with argon plasma coagulation and acid suppression: Immediate and mid term results. Gut 43, 747-751 (1998).
63. Bright, T. et al. randomized trial of argon plasma coagulation versus endoscopic surveillance for Barrett esophagus after antireflux surgery: Late results. Ann. Surg. 246, 1016-1020 (2007).
64. Pinotti, A. C. et al. endoscopic ablation of Barrett's esophagus using argon plasma coagulation: A prospective study after fundoplication. Dis. Esophagus 17, 243-246 (2004).
65. Attwood, S. E., Lewis, C. J., Caplin, S., Hemming, K. & Armstrong, G. Argon beam plasma coagulation as therapy for high-grade dysplasia in Barrett's esophagus. Clin. Gastroenterol. Hepatol. 1, 258-263 (2003).
66. Kahaleh, M., van Laethem, J. L., Nagy, N., Cremer, M. & Devière, J. Long-term follow-up and factors predictive of recurrence in Barrett's esophagus treated by argon plasma coagulation and acid suppression. Endoscopy 34, 950-955 (2002).
67. Basu, K. K., Pick, B., Bale, R., West, K. P. & de Caestecker, J. S. efficacy and one year follow up of argon plasma coagulation therapy for ablation of Barrett's oesophagus: Factors determining persistence and recurrence of Barrett's epithelium. Gut 51, 776-780 (2002).
68. Manner, H. et al. Ablation of nonneoplastic Barrett's mucosa using argon plasma coagulation with concomitant esomeprazole therapy (APBANEX): A prospective multicenter evaluation. Am. J. Gastroenterol. 101, 1762-1769 (2006).
69. Sharma, P. et al. A randomised controlled trial of ablation of Barrett's oesophagus with multipolar electrocoagulation versus argon plasma coagulation in combination with acid suppression: Long term results. Gut 55, 1233-1239 (2006).
70. Sampliner, R. E. et al. Effective and safe endoscopic reversal of nondysplastic Barrett's esophagus with thermal electrocoagulation combined with high-dose acid inhibition: A multicenter study. Gastrointest. Endosc. 53, 554-558 (2001).
71. Yeh, R. W. & Triadafilopoulos, G. endoscopic therapy for Barrett's esophagus. Gastrointest. Endosc. Clin. North Am. 15, 377-397 (2005).
72. Johnston, M. H. Technology insight: Ablative techniques for Barrett's esophagus - current and emerging trends. Nat. Clin. Pract. Gastroenterol. Hepatol. 2, 323-330 (2005).
73. Gossner, L. et al. KTP laser destruction of dysplasia and early cancer in columnar-lined Barrett's esophagus. Gastrointest Endosc. 49, 8-12 (1999).
74. El-Serag, H. B. et al. Proton pump inhibitors are associated with reduced incidence of dysplasia in Barrett's esophagus. Am. J. Gastroenterol. 99, 1877-1883 (2004).